MedTrace Logo

Pulse Oximetry Performance Test for PaMo - Controlled Desaturation Test

NCT07676227 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2026-06-30

No results posted yet for this study

Summary

The purpose of this study is to gather measurement data for the development and testing of a wearable patient monitor's pulse oximeter. The PaMo patient monitor measures respiratory rate, blood oxygen saturation, and electrocardiogram (ECG). The device transmits data via Bluetooth to a mobile application for immediate interpretation. The device, developed at Tampere University, aims to provide a wireless solution for monitoring patients' breathing and circulation, especially after surgical procedures. The collected data will be used to demonstrate the device's oxygen saturation measurement capability according to the European ISO 80601-2-61:2019 standard, contributing to further refinement of the solution.

Conditions

  • Vital Sign Monitoring
  • Vital Signs

Interventions

DEVICE

Hypoxia, intermittent

Controlled hypoxia induced with Hypoxico device

Sponsors & Collaborators

  • Tampere University

    lead OTHER

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-19
Primary Completion
2024-06-10
Completion
2025-12-31

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07676227 on ClinicalTrials.gov